One-Stop care boosts HIV prevention in transgender women

NCT ID NCT04742491

First seen Jan 07, 2026 · Last updated May 16, 2026 · Updated 19 times

Summary

This study tested a new approach to help transgender women in the Americas prevent HIV. It combined HIV prevention medication (PrEP) with gender-affirming hormone therapy and peer health coaching. 304 participants were randomly assigned to receive this combined care right away or after a 6-month wait. The goal was to see if this one-stop model made it easier for women to start and stick with PrEP.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV PREVENTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Bridge HIV CRS

    San Francisco, California, 94102, United States

  • Harlem Prevention Center CRS

    New York, New York, 10027, United States

  • Houston AIDS Research Team CRS

    Houston, Texas, 77030, United States

  • Instituto de Pesquisa Clinicaq Evandro Chagas CRS

    Manguinhos, Rio de Janeiro, 221045-900, Brazil

  • Penn Prevention CRS

    Philadelphia, Pennsylvania, 19104, United States

Conditions

Explore the condition pages connected to this study.